PULSESIGHT THERAPEUTICS Trademark

Trademark Overview


On Tuesday, April 23, 2024, a trademark application was filed for PULSESIGHT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PULSESIGHT THERAPEUTICS trademark a serial number of 79401614. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, May 21, 2025. This trademark is owned by PULSESIGHT THERAPEUTICS. The PULSESIGHT THERAPEUTICS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for the diagnostic and treatment of ophtalmic diseases; chemical-pharmaceuticals for the diagnostic and treatment of ophtalmic diseases; chemical products, biochemical products, biotechnological products for medical, pharmaceutical and veterinary purposes, namely, chemical reagents; biological, chemical, biochemical and biotechnological preparations for medical or pharmaceutical purposes, for the diagnosis and treatment of ocular disorders.

Medical services; health care; medical services in the field of ophthalmology and eye health.

Surgical apparatus and instruments; medical apparatus and instruments, namely electro-transfection delivery medical devices and medical injection devices, associated or not, for ophthalmic applications; ophthalmic surgical apparatus and instruments.

Medical research; medical and scientific research in the field of retinal medicine and treatments; medical and scientific research in the field of eye health; medical research in the field of ophthalmology; scientific research for medical purposes in the area of ophthalmology; scientific research for medical purposes in the area of retinal and ophthalmologic diseases and conditions; scientific research for medical purposes in the area of retinal and ophthalmologic treatments and pharmaceuticals; pharmaceutical research and development; pharmaceutical research and development for retinal and ophthalmologic diseases and conditions; pharmaceutical research and development for improving eye health.
pulsesight therapeutics

General Information


Serial Number79401614
Word MarkPULSESIGHT THERAPEUTICS
Filing DateTuesday, April 23, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, May 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2025

Trademark Statements


Goods and ServicesPharmaceuticals for the diagnostic and treatment of ophtalmic diseases; chemical-pharmaceuticals for the diagnostic and treatment of ophtalmic diseases; chemical products, biochemical products, biotechnological products for medical, pharmaceutical and veterinary purposes, namely, chemical reagents; biological, chemical, biochemical and biotechnological preparations for medical or pharmaceutical purposes, for the diagnosis and treatment of ocular disorders.
Goods and ServicesMedical services; health care; medical services in the field of ophthalmology and eye health.
NOT AVAILABLETHERAPEUTICS
Goods and ServicesSurgical apparatus and instruments; medical apparatus and instruments, namely electro-transfection delivery medical devices and medical injection devices, associated or not, for ophthalmic applications; ophthalmic surgical apparatus and instruments.
Goods and ServicesMedical research; medical and scientific research in the field of retinal medicine and treatments; medical and scientific research in the field of eye health; medical research in the field of ophthalmology; scientific research for medical purposes in the area of ophthalmology; scientific research for medical purposes in the area of retinal and ophthalmologic diseases and conditions; scientific research for medical purposes in the area of retinal and ophthalmologic treatments and pharmaceuticals; pharmaceutical research and development; pharmaceutical research and development for retinal and ophthalmologic diseases and conditions; pharmaceutical research and development for improving eye health.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePULSESIGHT THERAPEUTICS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Thursday, August 8, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, August 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 8, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, November 6, 2024ASSIGNED TO EXAMINER
Wednesday, November 13, 2024NON-FINAL ACTION WRITTEN
Tuesday, November 19, 2024REFUSAL PROCESSED BY MPU
Thursday, November 14, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 19, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 9, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 7, 2024REFUSAL PROCESSED BY IB